Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. ; Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.: Tuberculosis on antiretroviral therapy

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      Institute of Social and Preventive Medicine Bern (ISPM); Universität Bern Bern; Institute of Social and Preventive Medicine; University of Berne; Infectious Disease Epidemiology Unit; University of Cape Town; Department of Social Medicine; University of Bristol Bristol; University of North Carolina Chapel Hill (UNC); University of North Carolina System (UNC); Infectious Diseases Unit; Universidade Federal do Rio Grande do Sul Porto Alegre (UFRGS); British Columbia Centre for Excellence in HIV/AIDS; St. Paul's Hospital; Epidémiologie, santé publique et développement; Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR99-ISPED; CHU Bordeaux Bordeaux; Department of Infectious Diseases; Academic Medical Centre; San Franscisco AIDS Research Institute; University of California; Swiss HIV Cohort Study Data Center; Université de Lausanne (UNIL); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Universitat de Barcelona (UB); Department of primary care and population sciences; University College of London London (UCL); Mailman School of Public Health; Columbia University New York; Newlands clinic; Heineken International Health Affairs; Serviço de Doenças Infecciosas e Parasitárias; Universidade Federal do Rio de Janeiro (UFRJ)
    • بيانات النشر:
      HAL CCSD
      Oxford University Press (OUP)
    • الموضوع:
      2007
    • Collection:
      Archive ouverte HAL (Hyper Article en Ligne, CCSD - Centre pour la Communication Scientifique Directe)
    • نبذة مختصرة :
      International audience ; We examined the incidence of and risk factors for tuberculosis during the first year of highly active antiretroviral therapy in low-income (4540 patients) and high-income (22,217 patients) countries. Although incidence was much higher in low-income countries, the reduction in the incidence of tuberculosis associated with highly active antiretroviral therapy was similar: the rate ratio for months 7-12 versus months 1-3 was 0.48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/17990236; inserm-00170433; https://www.hal.inserm.fr/inserm-00170433; https://www.hal.inserm.fr/inserm-00170433/document; https://www.hal.inserm.fr/inserm-00170433/file/ART-LINC.pdf; PUBMED: 17990236
    • الرقم المعرف:
      10.1086/522986
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.947F2E8B